Skip to main
LFWD
LFWD logo

LFWD Stock Forecast & Price Target

LFWD Analyst Ratings

Based on 3 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Lifeward Ltd is projected to experience significant revenue growth, anticipated to rise from $29.0 million in 2025 to $336.5 million by 2032, indicating a robust revenue trajectory. This positive outlook is supported by a remarkable 86% year-over-year revenue growth, with Q4 2024 revenues reaching $7.5 million, reflecting a 23% quarter-over-quarter increase. The company's strategic partnerships and the expected launch of the next generation ReWalk 7.0 in 2025 further bolster expectations for sustained revenue growth and improved market positioning in the future.

Bears say

Lifeward Ltd is currently facing significant financial challenges, as indicated by a loss on extinguishment of debt, which suggests a deteriorating financial position and potential difficulties in managing liabilities. The absence of detailed financial performance metrics raises concerns about the company's revenue generation and growth prospects amid competitive pressure in the medical device industry. Furthermore, the lack of reported positive financial results undermines investor confidence in Lifeward's ability to sustain operations and innovate effectively in its therapeutic product offerings.

LFWD has been analyzed by 3 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of ReWalk Robotics Ltd and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About ReWalk Robotics Ltd (LFWD) Forecast

Analysts have given LFWD a Strong Buy based on their latest research and market trends.

According to 3 analysts, LFWD has a Strong Buy consensus rating as of Jul 23, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $9, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $9, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

ReWalk Robotics Ltd (LFWD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.